Details
| Original language | English |
|---|---|
| Pages (from-to) | 3809-3822 |
| Number of pages | 14 |
| Journal | Journal of Nutrition |
| Volume | 155 |
| Issue number | 11 |
| Early online date | 4 Sept 2025 |
| Publication status | Published - Nov 2025 |
Abstract
Background: Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides ratio has emerged as a potential biomarker for fiber responsiveness. Objectives: This study examined how stratified fiber supplementation affects microbial and metabolic outcomes in individuals with Prevotella (P-type)- or Bacteroides-dominated (B-type) microbiota. Methods: In this single-blinded, randomized crossover study, 23 healthy adults were classified as P-type (≥10% Prevotella) or B-type (≥10% Bacteroides) via 16S rRNA sequencing. Participants consumed 15 g/d of arabinoxylan (AX), inulin (INU), or placebo (PLA) for 1 wk each, with 2-wk washouts. After each phase, fasting and postprandial plasma SCFAs, branched-chain fatty acids (BCFAs), breath hydrogen, glucose, insulin, peptide YY, cholesterol, appetite ratings, and fecal microbiota were assessed. Data were analyzed using repeated-measures analysis of variance, the Friedman test, and multivariate microbiome analysis. Results: In P-types, AX increased fasting propionate compared with PLA (P = 0.04). In B-types, AX increased fasting propionate compared with INU (P = 0.02) and tended to elevate postprandial propionate compared with PLA in the first 60 min after breakfast (P = 0.05). AX also increased postprandial acetate compared with PLA in B-types (P = 0.04). INU reduced fasting BCFAs in B-types (P < 0.05) but did not increase SCFAs. Breath hydrogen varied widely in B-types after INU but not in P-types. Neither fiber affected glucose, insulin, or PYY. AX reduced appetite ratings in P-types (P < 0.05). INU increased Anaerostipes and Bifidobacterium and reduced Phocaeicola in both groups (q < 0.25). AX increased Fusicatenibacter in B-types (q = 0.18) and Paraprevotella in P-types (q = 0.17). Conclusions: B-types exhibited fiber-specific shifts in SCFA and BCFA metabolism and breath hydrogen, whereas P-types displayed a more limited overall response, with fewer metabolic and microbial parameters affected. These findings highlight the complexity of diet–microbiota interactions and support the potential relevance for microbiota-based nutrition strategies. This trial (PERIFIB) was registered at the German Clinical Trials register (DRKS) as DRKS00028898.
Keywords
- branched-chain fatty acids, enterotypes, fiber responsiveness, microbiota–diet interactions, personalized nutrition
ASJC Scopus subject areas
- Medicine(all)
- Medicine (miscellaneous)
- Nursing(all)
- Nutrition and Dietetics
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Journal of Nutrition, Vol. 155, No. 11, 11.2025, p. 3809-3822.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Microbiota-Dependent Fiber Responses
T2 - A Proof-of-Concept Study on Short-Chain Fatty Acid Production in Prevotella- and Bacteroides-Dominated Healthy Individuals
AU - Bartsch, Madeline
AU - Vital, Marius
AU - Woltemate, Sabrina
AU - Bouwman, Freek G.
AU - Berkemeyer, Shoma B.
AU - Hahn, Andreas
AU - Müller, Mattea
N1 - Publisher Copyright: © 2025 The Author(s)
PY - 2025/11
Y1 - 2025/11
N2 - Background: Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides ratio has emerged as a potential biomarker for fiber responsiveness. Objectives: This study examined how stratified fiber supplementation affects microbial and metabolic outcomes in individuals with Prevotella (P-type)- or Bacteroides-dominated (B-type) microbiota. Methods: In this single-blinded, randomized crossover study, 23 healthy adults were classified as P-type (≥10% Prevotella) or B-type (≥10% Bacteroides) via 16S rRNA sequencing. Participants consumed 15 g/d of arabinoxylan (AX), inulin (INU), or placebo (PLA) for 1 wk each, with 2-wk washouts. After each phase, fasting and postprandial plasma SCFAs, branched-chain fatty acids (BCFAs), breath hydrogen, glucose, insulin, peptide YY, cholesterol, appetite ratings, and fecal microbiota were assessed. Data were analyzed using repeated-measures analysis of variance, the Friedman test, and multivariate microbiome analysis. Results: In P-types, AX increased fasting propionate compared with PLA (P = 0.04). In B-types, AX increased fasting propionate compared with INU (P = 0.02) and tended to elevate postprandial propionate compared with PLA in the first 60 min after breakfast (P = 0.05). AX also increased postprandial acetate compared with PLA in B-types (P = 0.04). INU reduced fasting BCFAs in B-types (P < 0.05) but did not increase SCFAs. Breath hydrogen varied widely in B-types after INU but not in P-types. Neither fiber affected glucose, insulin, or PYY. AX reduced appetite ratings in P-types (P < 0.05). INU increased Anaerostipes and Bifidobacterium and reduced Phocaeicola in both groups (q < 0.25). AX increased Fusicatenibacter in B-types (q = 0.18) and Paraprevotella in P-types (q = 0.17). Conclusions: B-types exhibited fiber-specific shifts in SCFA and BCFA metabolism and breath hydrogen, whereas P-types displayed a more limited overall response, with fewer metabolic and microbial parameters affected. These findings highlight the complexity of diet–microbiota interactions and support the potential relevance for microbiota-based nutrition strategies. This trial (PERIFIB) was registered at the German Clinical Trials register (DRKS) as DRKS00028898.
AB - Background: Dietary fiber supports metabolic health via microbial fermentation, producing short-chain fatty acids (SCFAs). However, metabolic responses to fiber vary between individuals, potentially due to differences in gut microbiota composition. The Prevotella-to-Bacteroides ratio has emerged as a potential biomarker for fiber responsiveness. Objectives: This study examined how stratified fiber supplementation affects microbial and metabolic outcomes in individuals with Prevotella (P-type)- or Bacteroides-dominated (B-type) microbiota. Methods: In this single-blinded, randomized crossover study, 23 healthy adults were classified as P-type (≥10% Prevotella) or B-type (≥10% Bacteroides) via 16S rRNA sequencing. Participants consumed 15 g/d of arabinoxylan (AX), inulin (INU), or placebo (PLA) for 1 wk each, with 2-wk washouts. After each phase, fasting and postprandial plasma SCFAs, branched-chain fatty acids (BCFAs), breath hydrogen, glucose, insulin, peptide YY, cholesterol, appetite ratings, and fecal microbiota were assessed. Data were analyzed using repeated-measures analysis of variance, the Friedman test, and multivariate microbiome analysis. Results: In P-types, AX increased fasting propionate compared with PLA (P = 0.04). In B-types, AX increased fasting propionate compared with INU (P = 0.02) and tended to elevate postprandial propionate compared with PLA in the first 60 min after breakfast (P = 0.05). AX also increased postprandial acetate compared with PLA in B-types (P = 0.04). INU reduced fasting BCFAs in B-types (P < 0.05) but did not increase SCFAs. Breath hydrogen varied widely in B-types after INU but not in P-types. Neither fiber affected glucose, insulin, or PYY. AX reduced appetite ratings in P-types (P < 0.05). INU increased Anaerostipes and Bifidobacterium and reduced Phocaeicola in both groups (q < 0.25). AX increased Fusicatenibacter in B-types (q = 0.18) and Paraprevotella in P-types (q = 0.17). Conclusions: B-types exhibited fiber-specific shifts in SCFA and BCFA metabolism and breath hydrogen, whereas P-types displayed a more limited overall response, with fewer metabolic and microbial parameters affected. These findings highlight the complexity of diet–microbiota interactions and support the potential relevance for microbiota-based nutrition strategies. This trial (PERIFIB) was registered at the German Clinical Trials register (DRKS) as DRKS00028898.
KW - branched-chain fatty acids
KW - enterotypes
KW - fiber responsiveness
KW - microbiota–diet interactions
KW - personalized nutrition
UR - http://www.scopus.com/inward/record.url?scp=105016794940&partnerID=8YFLogxK
U2 - 10.1016/j.tjnut.2025.08.034
DO - 10.1016/j.tjnut.2025.08.034
M3 - Article
C2 - 40914513
AN - SCOPUS:105016794940
VL - 155
SP - 3809
EP - 3822
JO - Journal of Nutrition
JF - Journal of Nutrition
SN - 0022-3166
IS - 11
ER -